{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:39:26Z","timestamp":1789591166164,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Canc\u00e9rop\u00f4le Nord Ouest"}],"content-domain":{"domain":["thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.radonc.2015.06.007","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T10:28:40Z","timestamp":1434364120000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Primary tumor delineation based on 18FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy"],"prefix":"10.1016","volume":"116","clinical-trial-number":[{"clinical-trial-number":"nct00809016","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mathieu","family":"Leclerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lartigau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lacornerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Daisne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.06.007_b0005","series-title":"Technical basis of radiation therapy","first-page":"133","article-title":"Simulation in the determination and definition of treatment volume and treatment planning","author":"Mutic","year":"2012"},{"key":"10.1016\/j.radonc.2015.06.007_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0360-3016(99)00304-1","article-title":"The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study","volume":"46","author":"Wu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2012.02.010","article-title":"Heterogeneity in head and neck IMRT target design and clinical practice","volume":"103","author":"Hong","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0020","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.08.037","article-title":"Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer","volume":"61","author":"Paulino","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0025","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s00259-013-2513-9","article-title":"Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer","volume":"40","author":"Schinagl","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2015.06.007_b0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2011.07.025","article-title":"18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer","volume":"101","author":"Delouya","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2005.11.048","article-title":"Initial experience of FDG-PET\/CT guided IMRT of head-and-neck carcinoma","volume":"65","author":"Wang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0040","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2007.07.2333","article-title":"Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer","volume":"69","author":"Schinagl","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijrobp.2011.05.060","article-title":"Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination","volume":"83","author":"Thiagarajan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2010.04.025","article-title":"The potential advantages of (18)FDG PET\/CT-based target volume delineation in radiotherapy planning of head and neck cancer","volume":"97","author":"Moule","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiol.2331030660","article-title":"Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen","volume":"233","author":"Daisne","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2015.06.007_b0060","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00259-006-0363-4","article-title":"A gradient-based method for segmenting FDG-PET images: methodology and validation","volume":"34","author":"Geets","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2015.06.007_b0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2006.01.006","article-title":"Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies","volume":"78","author":"Geets","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines","volume":"69","author":"Gr\u00e9goire","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2008.04.010","article-title":"Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors","volume":"89","author":"Castadot","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0085","unstructured":"Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements, report 50, 1993."},{"key":"10.1016\/j.radonc.2015.06.007_b0090","unstructured":"Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). International Commission on Radiation Units and Measurements, report 62, 1999."},{"key":"10.1016\/j.radonc.2015.06.007_b0095","unstructured":"Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy IMRT. International Commission on Radiation Units and Measurements, report 83, 2010."},{"key":"10.1016\/j.radonc.2015.06.007_b0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94\u201301 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2015.06.007_b0110","doi-asserted-by":"crossref","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","article-title":"EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Gr\u00e9goire","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2004.03.014","article-title":"Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer","volume":"72","author":"Bussels","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1748-717X-8-132","article-title":"Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control","volume":"8","author":"Chajon","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijrobp.2007.10.010","article-title":"Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer","volume":"71","author":"Schoenfeld","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0360-3016(99)00550-7","article-title":"Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer","volume":"46","author":"Dawson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0135","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2012.08.004","article-title":"Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy","volume":"85","author":"Garden","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.oraloncology.2014.02.009","article-title":"Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing","volume":"50","author":"Dandekar","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0145","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1109\/TMI.2012.2202322","article-title":"Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy","volume":"31","author":"Shepherd","year":"2012","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.radonc.2015.06.007_b0150","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijrobp.2007.12.033","article-title":"Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy","volume":"72","author":"Murdoch-Kinch","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2013.05.004","article-title":"Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction","volume":"107","author":"van der Laan","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2011.11.001","article-title":"The potential benefit of swallowing sparing intensity modulated radiotherapy to reduces wallowing dysfunction: an in silico planning comparative study","volume":"103","author":"van der Laan","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2013.06.001","article-title":"Late dysphagia after IMRT for head and neck cancer and correlation with dose\u2013volume parameters","volume":"107","author":"Mortensen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0180","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijrobp.2007.08.052","article-title":"(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy","volume":"70","author":"Sura","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijrobp.2014.01.047","article-title":"Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDGPET scans in recurrent lung cancer","volume":"89","author":"Shusharina","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.06.007_b0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.radonc.2009.01.003","article-title":"Is pre-therapeutical FDG-PET\/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?","volume":"91","author":"Abramyuk","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0195","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3109\/0284186X.2013.812799","article-title":"Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer","volume":"52","author":"Hoeben","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semradonc.2010.10.001","article-title":"Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription","volume":"21","author":"Bentzen","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.06.007_b0205","doi-asserted-by":"crossref","unstructured":"Gr\u00e9goire V, Jeraj R, Lee JA, O\u2019Sullivan B. Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?","DOI":"10.1016\/S1470-2045(12)70237-1"},{"key":"10.1016\/j.radonc.2015.06.007_b0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2011.06.020","article-title":"Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer","volume":"101","author":"Madani","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015002881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015002881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T20:31:43Z","timestamp":1566851503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015002881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0167814015002881"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.06.007","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary tumor delineation based on 18FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}